Prenetics Group (PRE)
NASDAQ:PRE
Want to see PRE full AI Analyst Report?
PRE Stock Chart & Stats
$17.83
-$0.22(-3.97%)
At close: 4:00 PM EST
$17.83
-$0.22(-3.97%)
Day’s Range― - ―
52-Week Range$5.07 - $23.63
Previous CloseN/A
Volume5.03K
Average Volume (3M)170.32K
Market Cap
$277.67M
Enterprise Value$201.96M
Total Cash (Recent Filing)$61.49M
Total Debt (Recent Filing)$2.20M
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Jun 08, 2026EPS Estimate
-0.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.02
Shares Outstanding15,247,465
10 Day Avg. Volume145,161
30 Day Avg. Volume170,319
Financial Highlights & Ratios
PEG Ratio-0.27
Price to Book (P/B)1.27
Price to Sales (P/S)2.40
P/FCF Ratio-10.05
Enterprise Value/Market Cap0.73
Enterprise Value/Revenue2.12
Enterprise Value/Gross Profit4.01
Enterprise Value/Ebitda-4.92
Forecast
1Y Price Target
$32.50Price Target Upside82.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-3.15
Revenue Forecast (FY)$192.51M
Bulls Say, Bears Say
Bulls Say
Rapid IM8 Revenue ScaleAchieving a $120M ARR in under a year demonstrates durable product-market fit and rapid customer adoption. This scale provides a base for predictable subscription revenue, drives operating leverage, and materially improves the odds that future marketing and R&D investments will convert to long‑term profitable growth across markets.
High And Improving Gross MarginsSustained ~60%+ gross margins for the core IM8 product indicate attractive unit economics that persist as volume grows. High product margins create structural room to absorb marketing and SG&A during scale, accelerating the path from top‑line growth to operating profitability as unit fixed costs spread over higher volumes.
Strong Liquidity And Focused PortfolioA ~$171M liquidity buffer and zero net debt materially reduce funding risk while the company scales IM8. Proceeds from divestitures simplified the operating model and provide non‑dilutive capital to fund international expansion, trials, and marketing, improving execution flexibility over the next several quarters.
Bears Say
Negative Operating And Free Cash FlowDespite revenue acceleration, persistent negative operating and free cash flows indicate the business still consumes cash to grow. Continued cash burn requires the firm to rely on existing liquidity or future financing if margins or subscription economics don’t convert to positive cash generation, a structural risk to sustainability.
Near-term Adjusted EBITDA Losses PersistManagement’s plan extends meaningful adjusted EBITDA losses into 2026 while targeting late‑2027 breakeven. This multi‑year loss profile requires sustained execution on CAC, margin targets, and international expansion; any slippage could prolong losses and pressure liquidity despite current cash reserves.
High Revenue Concentration In IM8With roughly two‑thirds of revenue tied to a single brand, the company is exposed to concentration risk: brand, competitive, regulatory, or channel setbacks to IM8 would disproportionately impact consolidated growth and margins. Diversification remains incomplete and critical for long‑term stability.
Prenetics Group News
PRE FAQ
What was Prenetics Group’s price range in the past 12 months?
Prenetics Group lowest stock price was $5.07 and its highest was $23.63 in the past 12 months.
What is Prenetics Group’s market cap?
Prenetics Group’s market cap is $277.67M.
When is Prenetics Group’s upcoming earnings report date?
Prenetics Group’s upcoming earnings report date is Jun 08, 2026 which is in 34 days.
How were Prenetics Group’s earnings last quarter?
Prenetics Group released its earnings results on Feb 18, 2026. The company reported -$1.77 earnings per share for the quarter, missing the consensus estimate of -$0.33 by -$1.44.
Is Prenetics Group overvalued?
According to Wall Street analysts Prenetics Group’s price is currently Undervalued.
Does Prenetics Group pay dividends?
Prenetics Group pays a Quarterly dividend of $0.7 which represents an annual dividend yield of N/A. See more information on Prenetics Group dividends here
What is Prenetics Group’s EPS estimate?
Prenetics Group’s EPS estimate is -0.82.
How many shares outstanding does Prenetics Group have?
Prenetics Group has 15,247,465 shares outstanding.
What happened to Prenetics Group’s price movement after its last earnings report?
Prenetics Group reported an EPS of -$1.77 in its last earnings report, missing expectations of -$0.33. Following the earnings report the stock price went down -7.728%.
Which hedge fund is a major shareholder of Prenetics Group?
Currently, no hedge funds are holding shares in PRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Prenetics Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.50 (82.28% Upside)
$32.50 (82.28% Upside)
Blogger Sentiment
Bullish
PRE Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▲ 6.2%
Last 30 Days ▲ 6.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
344.63%
12-Months-Change
Fundamentals
Return on Equity
-36.02%
Trailing 12-Months
Asset Growth
-4.71%
Trailing 12-Months
Company Description
Prenetics Group
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRE Company Deck
PRE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strongly positive operational and financial transformation driven by IM8: exceptional top-line growth (FY revenue +480% YoY), rapid product-market fit (IM8 $120M run rate), improving gross margins (~59% consolidated; IM8 63%), healthy unit economics (LTV:CAC ~3x; payback ~3.4 months) and a fortified balance sheet (~$171M liquidity, 0 debt). Near-term risks include ongoing adjusted EBITDA losses with FY2026 guidance widening to $16M–$20M as the company invests to scale, revenue concentration in IM8 (~65% of FY2025 revenue), historical CAC inefficiency in 2025, reliance on intensive marketing spend, and residual crypto exposure. Overall, the positive growth trajectory, margin profile, and strong liquidity substantially outweigh the near-term profitability and concentration risks.View all PRE earnings summariesPRE Stock 12 Month Forecast
Average Price Target
$32.50
▲(82.28% Upside)
Technical Analysis
Ownership Overview
―
Insiders
0.04% Mutual Funds
0.18% Other Institutional Investors
99.57% Public Companies and
Individual Investors